Miljkovic Milos has filed 18 insider transactions across 1 company since November 2023.
Most recent transaction: a sale of 3573 shares of Cartesian Therapeutics, Inc. ($RNAC) on January 06, 2026.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 6, 2026 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | S | Common Stock | 3573 | $6.82 | 58,820.0000 | 26,003,606 | 5.73% | 0.01% |
| Jan. 2, 2026 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | A | Employee Stock Option (right to buy) | 77000 | $0.00 | 77,000.0000 | 26,003,606 | 9999.99% | 0.30% |
| Jan. 2, 2026 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | A | Common Stock | 27000 | $0.00 | 62,393.0000 | 26,003,606 | 76.29% | 0.10% |
| Jan. 3, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | S | Common Stock | 932 | $16.72 | 36,341.0000 | 25,767,369 | 2.50% | 0.00% |
| Jan. 6, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | S | Common Stock | 948 | $16.83 | 35,393.0000 | 25,767,369 | 2.61% | 0.00% |
| Jan. 2, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | A | Common Stock | 19000 | $0.00 | 37,273.0000 | 25,767,369 | 103.98% | 0.07% |
| Jan. 2, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | A | Employee Stock Option (right to buy) | 56000 | $0.00 | 56,000.0000 | 25,767,369 | 9999.99% | 0.22% |
| Nov. 15, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | S | Common Stock | 20000 | $17.14 | 18,273.0000 | 23,896,525 | 52.26% | 0.08% |
| Nov. 14, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | M | Stock Option (Right to Buy) | 35000 | $0.00 | 50,528.0000 | 23,896,525 | 40.92% | 0.15% |
| Nov. 15, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 30,528.0000 | 23,896,525 | 39.58% | 0.08% |
| Nov. 14, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | S | Common Stock | 35000 | $16.13 | 18,273.0000 | 23,896,525 | 65.70% | 0.15% |
| Nov. 15, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | M | Common Stock | 20000 | $3.23 | 38,273.0000 | 23,896,525 | 109.45% | 0.08% |
| Nov. 14, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | M | Common Stock | 35000 | $3.23 | 53,273.0000 | 23,896,525 | 191.54% | 0.15% |
| April 8, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | M | Stock Option (Right to Buy) | 2566 | $0.00 | 23,433.0000 | 5,515,836 | 9.87% | 0.05% |
| April 8, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | M | Stock Option (Right to Buy) | 85528 | $0.00 | 108,961.0000 | 5,515,836 | 364.99% | 1.55% |
| Jan. 2, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | A | Employee Stock Option (right to buy) | 703000 | $0.00 | 703,000.0000 | 5,397,597 | 9999.99% | 13.02% |
| Jan. 2, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | A | Common Stock | 548200 | $0.00 | 548,200.0000 | 5,397,597 | 9999.99% | 10.16% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Miljkovic Milos | Chief Medical Officer | A | Stock Option (Right to Buy) | 2566 | $0.00 | 2,565.8720 | 5,101,459 | 9999.99% | 0.05% |